Kilitch Drugs (India) Ltd share price logo

Kilitch Drugs (India) Ltd (KILITCH)

₹334.41.17%

bell
Get free price alerts. Set up your Free investment account to get Live Prices.
Overview
News
Financials
Q3 '23 Results
Technicals

Performance

  • Day's Low

    Day's High

    ₹333
    ₹344
  • 52 Week's Low

    52 Week's High

    ₹175
    ₹470
1 Month Return+ 2.72 %
3 Month Return-4.27 %
1 Year Return+ 81.15 %
Previous Close₹338.35
Open₹344.00
Volume5,071.00
Upper Circuit-
Lower Circuit-
Market Cap₹537.79Cr

Key Statistics

P/E Ratio36.47
PEG Ratio14.82
Market Cap₹537.79 Cr
P/B Ratio1.14
EPS5.32

Company Information

Kilitch Drugs India Ltd (KDIL) is a pharmaceutical company that was incorporated in May 1992 and has since gone public in Feb. 1994. They manufactures a range of pharmaceutical products including tablets, capsules, liquid orals, ointments, creams and injectables. They operate two divisions for OTC and ethical drugs, with additional manufacturing plants located in India, Ethiopia, Republic of Yemen and Patalganga Maharashtra, India. KDIL also provides exports for Sudan, Yemen, the Middle East, Miami and some South American countries. In 2011, they introduced a new product BENIN. In 2012, their undertakings located at Paonta Sahib in Himachal Pradesh were sold and transferred, while certain products were transferred to Akorn India Pvt. Ltd. KDIL's range of pharmaceutical services ensures safe and quality solutions for their customers.

Share Price: ₹334.40 per share as on 15 Jul, 2024 04:01 PM
Market Capitalisation: ₹537.79Cr as of today
Revenue: ₹44.82Cr as on March 2024 (Q1 24)
Net Profit: ₹3.68Cr as on March 2024 (Q1 24)
Listing date: 29 Sep, 2010
Chairperson Name: Mukund P Mehta
OrganisationKilitch Drugs (India) Ltd
HeadquartersMumbai
IndustryPharmaceuticals
E-voting on sharesClick here to vote

Key events for Kilitch Drugs (India) Ltd

  • Kilitch Healthcare India Receives Warning Letter from USFDA - 12 Apr, 2024

    The US Food and Drug Administration (USFDA) has issued a warning letter to Kilitch Healthcare India for manufacturing lapses, including packing drugs in insanitary conditions at its Maharashtra-based plant. The Navi-Mumbai plant produces finished pharmaceuticals.

  • Kilitch Healthcare India Receives Warning Letter from USFDA - 11 Apr, 2024

    The US Food and Drug Administration (USFDA) has issued a warning letter to Kilitch Healthcare India for significant violations of current good manufacturing practice regulations, including packing drugs in insanitary conditions at its Maharashtra-based plant.

Insights on Kilitch Drugs (India) Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, 2.91 Cr → 3.59 Cr (in ₹), with an average increase of 18.9% per quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 34.75 Cr → 45.29 Cr (in ₹), with an average increase of 23.3% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 130.9% return, outperforming this stock by 11.9%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 69.23% of holdings in Jun 2024 quarter

  • imgNO EFFECT

    Retail Holding Unchanged

    img

    Retail Investor holdings remained unchanged at 30.77% of holdings in Jun 2024 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Zydus Lifesciences Ltd has given 94.9% return, outperforming this stock by 11.6%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 6 months, KILITCH stock has moved down by -16.2%

Company Financials

Value in ₹ crore
Q'1 24Q/Q Change
Revenue
₹44.82Cr
↑40.99%
Net Income
₹3.68Cr
↑111.49%
Net Profit Margin
8.21%
↑50.09%
2023Y/Y Change
Revenue
₹139.60Cr
↑22.21%
Net Income
₹8.28Cr
↑33.33%
Net Profit Margin
5.93%
↑9.01%
Value in ₹ crore
2023Y/Y Change
Total Assets
₹252.41Cr
↑8.67%
Total Liabilities
₹56.48Cr
↑4.11%
Value in ₹ crore
2023Y/Y Change
Operating Cash Flow
₹6.10Cr
↑17.08%

Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
69.23%
0.00
Foreign Institutions
0%
-100.00
Mutual Funds
0%
0.00
Retail Investors
30.77%
0.00
Others
0%
0.00

Key Indicators

Kilitch Drugs (India) Ltd Valuation

Kilitch Drugs (India) Ltd in the last 5 years

  • Overview

  • Trends

Lowest (-986.00x)

July 3, 2019

Today (36.47x)

July 15, 2024

Industry (56.26x)

July 15, 2024

Highest (363.79x)

October 16, 2020

LowHigh

Earnings and Dividends

  • Kilitch Drugs (India) Ltd Earnings Results

    Kilitch Drugs (India) Ltd’s net profit jumped 0.84% since last year same period to ₹3.59Cr in the Q4 2023-2024. On a quarterly growth basis, Kilitch Drugs (India) Ltd has generated 23.37% jump in its net profits since last 3-months.

    Read More about Earnings Results
  • Kilitch Drugs (India) Ltd Dividends May,2019

    In the quarter ending March 2019, Kilitch Drugs (India) Ltd has declared dividend of ₹0.50 - translating a dividend yield of 0.15%.

    Read More about Dividends

Technicals Summary

Bearish

Neutral

Bullish

Bearish

Kilitch Drugs (India) Ltd is currently in a Bearish trading position according to technical analysis indicators.

Frequently Asked Questions

  • Get a PAN card.
  • Open a Demat account.
  • Open a Trading account.
  • Link your Demat account to your Trading account.
  • Fund your Trading account.
  • Place an order to buy Kilitch Drugs (India) Ltd shares.

Kilitch Drugs (India) Ltd (KILITCH) share price today is ₹334.4

Kilitch Drugs (India) Ltd is listed on NSE

Kilitch Drugs (India) Ltd is listed on BSE

  • Today’s highest price of Kilitch Drugs (India) Ltd is ₹344.
  • Today’s lowest price of Kilitch Drugs (India) Ltd is ₹333.

PE Ratio of Kilitch Drugs (India) Ltd is 36.47

PE ratio = Kilitch Drugs (India) Ltd Market price per share / Kilitch Drugs (India) Ltd Earnings per share

Today’s traded volume of Kilitch Drugs (India) Ltd(KILITCH) is 5,071.00.

Today’s market capitalisation of Kilitch Drugs (India) Ltd(KILITCH) is ₹537.79Cr.

Kilitch Drugs (India) Ltd(KILITCHPrice
52 Week High
₹470
52 Week Low
₹175

Kilitch Drugs (India) Ltd(KILITCH) share price is ₹334.4. It is down -28.85% from its 52 Week High price of ₹470

Kilitch Drugs (India) Ltd(KILITCH) share price is ₹334.4. It is up 91.09% from its 52 Week Low price of ₹175

Kilitch Drugs (India) Ltd(KILITCHReturns
1 Day Returns
-3.95%
1 Month Returns
2.72%
3 Month Returns
-4.27%
1 Year Returns
81.15%